open access
Disseminated medullary thyroid cancer — an alternative therapeutic approach
Affiliations- Students’ Scientific Group of Endocrinology at the Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
- Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
open access
Abstract
Not required for Clinical Vignette.
Abstract
Not required for Clinical Vignette.
Keywords
medullary thyroid cancer; vandetanib; lanreotide; PRRT; targeted radiotherapy
About this articleTitle
Disseminated medullary thyroid cancer — an alternative therapeutic approach
Journal
Issue
Article type
Clinical vignette
Pages
909-910
Published online
2022-07-18
Page views
4222
Article views/downloads
443
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2022;73(5):909-910.
Keywords
medullary thyroid cancer
vandetanib
lanreotide
PRRT
targeted radiotherapy
Authors
Maja Wilczyńska
Mateusz Suchmiel
Grzegorz Sokołowski
Alicja Hubalewska-Dydejczyk
Małgorzata Trofimiuk-Müldner
References (9)- Viola D, Elisei R. Management of Medullary Thyroid Cancer. Endocrinol Metab Clin North Am. 2019; 48(1): 285–301.
- Lee DY, Kim YI. Peptide Receptor Radionuclide Therapy in Patients With Differentiated Thyroid Cancer: A Meta-analysis. Clin Nucl Med. 2020; 45(8): 604–610.
- Giardino E, Catalano R, Mangili F, et al. Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion. Mol Cell Endocrinol. 2021; 520: 111092.
- Díez JJ, Iglesias P. Somatostatin analogs in the treatment of medullary thyroid carcinoma. J Endocrinol Invest. 2002; 25(9): 773–778.
- Cano JM, Galán R, López R. Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged Treatment with Somatostatin Analogues. Thyroid. 2017; 27(11): 1450–1455.
- Vitale G, Lupoli G, Guarrasi R, et al. Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies. J Clin Endocrinol Metab. 2013; 98(10): E1567–E1574.
- Wells SA, Asa SL, Dralle H, et al. American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015; 25(6): 567–610.
- Schlumberger M, Bastholt L, Dralle H, et al. European Thyroid Association Task Force. 2012 European thyroid association guidelines for metastatic medullary thyroid cancer. Eur Thyroid J. 2012; 1(1): 5–14.
- NCCN Clinical Practice Guidelines in Oncology. 15 Oct. 2021. Thyroid Carcinoma. https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf (Accessed 24 Feb 2022).
